EICHORCondition: Colorectal Cancer · Colorectal Adenoma · Sponsor: Helse Nord-Trøndelag HF
Interested? Contact the study team ↓
CoLiQ is a clinical study designed to evaluate the clinical usefulness of circulating tumor DNA (ctDNA) markers found in blood, as a liquid biopsy for diagnosis, prognosis and follow-up of colorectal cancer. The main questions it aims to answer are: 1) Can a panel of ctDNA markers identify CRC patients among the other patients summoned for colonoscopy? and 2) Does the type, number and level of ctDNA markers vary with the subtype and clinical course of CRC? Participants will be asked to answer a questionnaire and give a blood sample at inclusion. In addition, patients with CRC will be asked to give an extra test tube at their routine treatment and follow-up blood sampling.
This description comes directly from the study's public registry record.
Eivor A Laugsand, MD, PhD · +47 74075180 · eivor.a.laugsand@ntnu.no
Siv S Brenne, MD · +47 74075180 · siv.s.brenne@ntnu.no
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Patient ≥ 18 years old summoned for colonoscopy * Patient able to understand and sign written informed consent Exclusion Criteria: * Patient \< 18 years old * Patient unable to understand or give written informed consent * Patient unlikely to comply with the protocol (e.g. uncooperative attitude, inability to return for subsequent visits) and/or otherwise considered by the investigator as unlikely to complete the study
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Nord-Trøndelag Hospital Trust | Levanger, Norway | Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06307938